» Articles » PMID: 35353047

Using Named Entity Recognition to Identify Substances Used in the Self-medication of Opioid Withdrawal: Natural Language Processing Study of Reddit Data

Overview
Journal JMIR Form Res
Publisher JMIR Publications
Date 2022 Mar 30
PMID 35353047
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The cessation of opioid use can cause withdrawal symptoms. People often continue opioid misuse to avoid these symptoms. Many people who use opioids self-treat withdrawal symptoms with a range of substances. Little is known about the substances that people use or their effects.

Objective: The aim of this study is to validate a methodology for identifying the substances used to treat symptoms of opioid withdrawal by a community of people who use opioids on the social media site Reddit.

Methods: We developed a named entity recognition model to extract substances and effects from nearly 4 million comments from the r/opiates and r/OpiatesRecovery subreddits. To identify effects that are symptoms of opioid withdrawal and substances that are potential remedies for these symptoms, we deduplicated substances and effects by using clustering and manual review, then built a network of substance and effect co-occurrence. For each of the 16 effects identified as symptoms of opioid withdrawal in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, we identified the 10 most strongly associated substances. We classified these pairs as follows: substance is a Food and Drug Administration-approved or commonly used treatment for the symptom, substance is not often used to treat the symptom but could be potentially useful given its pharmacological profile, substance is a home or natural remedy for the symptom, substance can cause the symptom, or other or unclear. We developed the Withdrawal Remedy Explorer application to facilitate the further exploration of the data.

Results: Our named entity recognition model achieved F scores of 92.1 (substances) and 81.7 (effects) on hold-out data. We identified 458 unique substances and 235 unique effects. Of the 130 potential remedies strongly associated with withdrawal symptoms, 54 (41.5%) were Food and Drug Administration-approved or commonly used treatments for the symptom, 17 (13.1%) were not often used to treat the symptom but could be potentially useful given their pharmacological profile, 13 (10%) were natural or home remedies, 7 (5.4%) were causes of the symptom, and 39 (30%) were other or unclear. We identified both potentially promising remedies (eg, gabapentin for body aches) and potentially common but harmful remedies (eg, antihistamines for restless leg syndrome).

Conclusions: Many of the withdrawal remedies discussed by Reddit users are either clinically proven or potentially useful. These results suggest that this methodology is a valid way to study the self-treatment behavior of a web-based community of people who use opioids. Our Withdrawal Remedy Explorer application provides a platform for using these data for pharmacovigilance, the identification of new treatments, and the better understanding of the needs of people undergoing opioid withdrawal. Furthermore, this approach could be applied to many other disease states for which people self-manage their symptoms and discuss their experiences on the web.

Citing Articles

The Use of Natural Language Processing Methods in Reddit to Investigate Opioid Use: Scoping Review.

Almeida A, Patton T, Conway M, Gupta A, Strathdee S, Borquez A JMIR Infodemiology. 2024; 4:e51156.

PMID: 39269743 PMC: 11437337. DOI: 10.2196/51156.


Investigating Substance Use via Reddit: Systematic Scoping Review.

Chi Y, Chen H J Med Internet Res. 2023; 25:e48905.

PMID: 37878361 PMC: 10637357. DOI: 10.2196/48905.


Using GPT-3 to Build a Lexicon of Drugs of Abuse Synonyms for Social Media Pharmacovigilance.

Carpenter K, Altman R Biomolecules. 2023; 13(2).

PMID: 36830756 PMC: 9953178. DOI: 10.3390/biom13020387.


Social Media Mining of Long-COVID Self-Medication Reported by Reddit Users: Feasibility Study to Support Drug Repurposing.

Koss J, Bohnet-Joschko S JMIR Form Res. 2022; 6(10):e39582.

PMID: 36007131 PMC: 9531770. DOI: 10.2196/39582.

References
1.
Unnithan S, Gossop M, Strang J . Factors associated with relapse among opiate addicts in an out-patient detoxification programme. Br J Psychiatry. 1992; 161:654-7. DOI: 10.1192/bjp.161.5.654. View

2.
Mannelli P, Peindl K, Lee T, Bhatia K, Wu L . Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives. Curr Drug Abuse Rev. 2012; 5(1):52-63. PMC: 3496559. DOI: 10.2174/1874473711205010052. View

3.
Gowing L, Farrell M, Ali R, White J . Alpha₂-adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev. 2016; (5):CD002024. PMC: 7081129. DOI: 10.1002/14651858.CD002024.pub5. View

4.
Krupitsky E, Ilyuk R, Mikhailov A, Kazankov K, Rybakova K, Skurat E . [A randomized single blind study of the efficacy of pregabalin in the treatment of opioid withdrawal syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova. 2016; 116(7):29-36. DOI: 10.17116/jnevro20161167129-36. View

5.
Eban K . Painful medicine. Fortune. 2012; 164(8):142-5, 147-8, 150 passim. View